Curium (Mallinckrodt Nuclear Medicine LLC)

Nuclear Medicine Solutions Provider

Based in MO

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $30K in lobbying spend across 6 quarterly filings, Curium (Mallinckrodt Nuclear Medicine LLC) is an active lobbying client. Their lobbying covers 1 issue area.

$30K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$30K

Issues Lobbied

Energy

Lobbying Firms

Jim Massie & Partners, LLC

Lobbyists

Tara BillingsleyJames MassieAllison Trexler

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Energy

  • •H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Ed
  • •H.R. 5515 - National Defense Authorization Act for Fiscal Year 2018
  • •S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Peabody Investments Corp
$6.6M total spend
American Soybean Association
$5.5M total spend
Burns & Mcdonnell Engineering Company INC
$2.6M total spend
Eaglepicher Technologies LLC
$2.1M total spend
Nidec Americas Holding Corporation
$1.9M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.